Ines Simeone

Post Doc

Research Lines

Genomic Science



IIT Publications

  • 2018
  • Ghini F., Rubolino C., Climent M., Simeone I.iit, Marzi M.J., Nicassio F.

    Endogenous transcripts control miRNA levels and activity in mammalian cells by target-directed miRNA degradation.

    Nature Communications, vol. 9, pp. 3119
  • 2017
  • Hendrickx W., Simeone I., Anjum S., Mokrab Y., Bertucci F., Finetti P., et al.

    Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis.

  • Marzi M.J.iit, Ghini F., Rubolino C., Simeone I.iit, Nicassio F.iit

    Study of Target-Induced miRNA Degradation by CRISPR/Cas9 deletion of miRNA responsive elements

  • 2016
  • Bedognetti D., Hendrickx W., Simeone I., Anjum S., Mokrab Y., Milles L. D., et al.

    Defining genetic modulators of intratumoral immune response in breast cancer through a system biology approach.

    Qatar Foundation Annual Research Conference Proceedings
  • 2015
  • Remo A., Simeone I., Pancione M., et al.

    Remo, A., Birnbaum, D., Manfrin, E., Bonetti, F., Bertucci, F., Bensmail, H., ... & Finetti, P. (2015). Systems biology analysis of gene expression data and gene network reverse-engineering approaches reveal NFAT5 as a candidate biomarker in Inflammatory Breast Cancer.

    Journal for ImmunoTherapy of Cancer
  • Remo A., Simeone I., Pancione M., Parcesepe P., Finetti P., Cerulo L., et al.

    Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer.

    Journal of Translational Medicine
  • Simeone I., Hendrickx W., Miller L., Bensmail H., Wang E., Marincola F., et al.

    Toward the identification of genetic determinants of breast cancer immune responsiveness.

    Journal for ImmunoTherapy of Cancer
  • 2014
  • Manfrin E., Remo A., Pancione M., Cannizzaro C., Falsirollo F., Pollini GP., Pellini F., Molino A., Brunelli M., Vendraminelli R., Ceccarelli M., Pagnotta SM., Simeone I., Bonetti F.

    Comparison between invasive breast cancer with extensive peritumoral vascular invasion and inflammatory breast carcinoma: A clinicopathologic study of 161 cases.

    American Journal of Clinical Pathology